The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Fefol Spansule 150 mg/0.5 mg Modified Release Capsules

Intapharm Labs LtdPA23101/001/001

Main Information

Trade NameFefol Spansule 150 mg/0.5 mg Modified Release Capsules
Active SubstancesDried ferrous sulphate
Folic acid
Dosage FormModified-release capsule, hard
Licence HolderIntapharm Labs Ltd
Licence NumberPA23101/001/001

Group Information

ATC CodeB03AD Iron in combination with folic acid
B03AD03 ferrous sulfate


License statusAuthorised
Licence Issued01/04/1980
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back